JSBio operates a rigorous quality management system supported by key certifications and regulatory filings, including ISO 13485/9001, GMP, a Class I medical device filing for cell culture media, and FDA DMFs. The system integrates ICH Q7, the Chinese Pharmacopoeia, ISPE best practices, and WHO guidance to ensure global compliance and local regulatory alignment across R&D and commercial manufacturing.

Comprehensive testing covers physicochemical, biological, and functional performance attributes, with advanced analytical methods (e.g., SEC, AEX, CEX, RP, HIC, CE-SDS, LC-MS) applied to critical quality attributes.

A robust quality risk management framework spans materials, manufacturing, testing, and post-market activities, validated through extensive internal and external audits across biopharma, vaccines, and cell & gene therapy worldwide.